The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...

The FDA has approved Journavax to be taken twice per day for adults, with Vertex noting that it’s not known whether or not the painkiller is safe for children. Vertex said it had established a ...

Vertex began researching the drug in the 2000s, when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain.

The landscape of prescription painkillers in America has transformed from a medical solution into a national crisis that touches every community. These medications, classified as opioids ...

Vertex Pharmaceuticals A new painkiller has been approved for the first time in 25 years — and there's no risk of addiction, experts say. On Thursday, Jan. 30, The U.S. Food and Drug ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at least as effective and costs only 50 cents a pill? They will if the ...

principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain. Prescriptions have fallen sharply in the last decade and the current wave of the ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term moderate-to-severe pain in adults. It’s the first of a new class of ...

THURSDAY, Jan. 30, 2025 (HealthDay News) -- People of color now have less access to prescription opioid painkillers than white patients, an unintended consequence of efforts to stem America’s ...